LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Best shares to buy now: 3 UK stocks I’d snap up today

    Our writer identifies three of the best shares to buy now for his portfolio and explains why he would consider…

    Read more »

    Investing Articles

    UK shares I’d buy as the economy recovers 

    With the UK economy in a pretty sweet spot and rising stock markets, what is Manika Premsingh buying?

    Read more »

    Investing Articles

    Here’s why AstraZeneca shares are a great buy for me

    AstraZeneca is a low-risk stock, but it has also given strong returns over time.

    Read more »

    Investing Articles

    Pharma stock investing: Biogen vs AstraZeneca

    Biogen has had its breakthrough Alzheimer's drug approved and AstraZeneca has several exciting drugs in development. Are these pharma stocks…

    Read more »

    Investing Articles

    1 FTSE 100 and 1 FTSE 250 stock to buy

    This Fool highlights one FTSE 100 and one FTSE 250 stock that he would buy for his portfolio for large…

    Read more »

    Investing Articles

    ESG investing: should I buy these 2 UK shares?

    As ESG investing grows, Christopher Ruane digs into the pros and cons of adding two UK shares with environmental and…

    Read more »

    Investing Articles

    The AstraZeneca share price is climbing. Is growth really here again?

    The AstraZeneca share price has been volatile in recent years, though we've seen a strong run since March. Will I…

    Read more »

    Investing Articles

    4 FTSE 100 shares I’d buy in June

    I've got my eye on four FTSE 100 stocks to buy and hold for five to 10 years. These are…

    Read more »

    Investing Articles

    GlaxoSmithKline shares: why I’m not buying

    GlaxoSmithKline has been popular with investors for decades. Despite this, Dan Peeke is wary of investing in the pharmaceutical giant.

    Read more »

    Investing Articles

    AstraZeneca stock: time to sell?

    Looking beyond the company’s vaccine woes, is now the time to make the most of the uptick in AstraZeneca stock…

    Read more »

    Investing Articles

    The AstraZeneca share price is rising fast. Here’s what I’d do now

    The AstraZeneca share price is rising fast after its robust results. But can it rise much further from its already…

    Read more »

    Investing Articles

    ESG investing: which UK companies might I invest in?

    A look at ESG investing and two UK FTSE 100 companies with strong ESG credentials, which might make them appealing…

    Read more »